BIO-key International, Inc. Common Stock • BKYI

Capital at risk.

About BIO-key International, Inc. Common Stock
Ticker
info
BKYI
Trading on
info
NASDAQ
ISIN
info
US09060C6066
Industry
info
Security & Protection Services
Sector
info
Industrials
CEO
info
Michael W. DePasquale
Headquarters
info
101 Crawfords Corner Road, Holmdel, NJ, United States, 07753
Employees
info
41
Website
info
bio-key.com
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Metrics
BasicAdvanced
Market cap
info
$4.1M
P/E ratio
info
-
EPS
info
-$9.40
Dividend Yield
info
0.00%
Beta
info
0.43
Forward P/E ratio
info
0
EBIDTA
info
$-3.5M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.1M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
0.63
Price to book
info
0.92
Earnings
EPS
info
-$9.40
EPS estimate (current quarter)
info
-$0.60
EPS estimate (next quarter)
info
-$0.80
EBITDA
info
$-3.5M
Revenues (TTM)
info
$6.5M
Revenues per share (TTM)
info
$8.04
Technicals
Beta
info
0.43
52-week High
info
$13.80
52-week Low
info
$3.00
50-day moving average
info
$4.38
200-day moving average
info
$5.88
Short ratio
info
0.45
Short %
info
6.10%
Management effectiveness
ROE (TTM)
info
-106.71%
ROA (TTM)
info
-24.85%
Profit margin
info
-102.32%
Gross profit margin
info
$5M
Operating margin
info
-7.35%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
33.50%
Share stats
Outstanding Shares
info
1.1M
Float
info
1M
Insiders %
info
11.44%
Institutions %
info
4.05%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$20.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$1.45
-$2.40
39.58%
Q1 • 25Beat
-$2.00
-$1.50
-33.33%
Q2 • 25Missed
-$1.49
-$1.20
-24.17%
Q3 • 25Missed
-$0.13
-$0.60
78.33%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2.1M
$-0.2M
-7.69%
Q1 • 26
$1.9M
$-0.6M
-30.04%
Q2 • 26
-10.51%
249.53%
290.59%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$10.7M
$3.3M
30.43%
Q1 • 26
$7.5M
$3.1M
42.07%
Q2 • 26
-29.95%
-3.16%
38.25%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.4M
-
$-0M
$-0.4M
Q1 • 26
$-0.8M
-
$0M
$-0.8M
Q2 • 26
136.24%
-
-120.06%
136.24%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a BIO-key International, Inc. Common Stock share?
Collapse

BIO-key International, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does BIO-key International, Inc. Common Stock have?
Collapse

BIO-key International, Inc. Common Stock currently has 1.1M shares.

Does BIO-key International, Inc. Common Stock pay dividends?
Collapse

No, BIO-key International, Inc. Common Stock doesn't pay dividends.

What is BIO-key International, Inc. Common Stock 52 week high?
Collapse

BIO-key International, Inc. Common Stock 52 week high is $13.80.

What is BIO-key International, Inc. Common Stock 52 week low?
Collapse

BIO-key International, Inc. Common Stock 52 week low is $3.00.

What is the 200-day moving average of BIO-key International, Inc. Common Stock?
Collapse

BIO-key International, Inc. Common Stock 200-day moving average is $5.88.

Who is BIO-key International, Inc. Common Stock CEO?
Collapse

The CEO of BIO-key International, Inc. Common Stock is Michael W. DePasquale.

How many employees BIO-key International, Inc. Common Stock has?
Collapse

BIO-key International, Inc. Common Stock has 41 employees.

What is the market cap of BIO-key International, Inc. Common Stock?
Collapse

The market cap of BIO-key International, Inc. Common Stock is $4.1M.

What is the P/E of BIO-key International, Inc. Common Stock?
Collapse

The current P/E of BIO-key International, Inc. Common Stock is null.

What is the EPS of BIO-key International, Inc. Common Stock?
Collapse

The EPS of BIO-key International, Inc. Common Stock is -$9.40.

What is the PEG Ratio of BIO-key International, Inc. Common Stock?
Collapse

The PEG Ratio of BIO-key International, Inc. Common Stock is 0.

What do analysts say about BIO-key International, Inc. Common Stock?
Collapse

According to the analysts BIO-key International, Inc. Common Stock is considered a buy.